Cargando…

Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection

COVID-19 infection displays heterogeneity of clinical manifestations in symptomatic and asymptomatic patients. We report on a child with Miller Fischer syndrome (MFS) and posterior reversible encephalopathy syndrome (PRES) post-COVID-19 infection. An 11-year-old boy presented with vomiting, headache...

Descripción completa

Detalles Bibliográficos
Autor principal: Al Haboob, Ali A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Riyadh : Armed Forces Hospital 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926123/
https://www.ncbi.nlm.nih.gov/pubmed/34230086
http://dx.doi.org/10.17712/nsj.2021.3.20210002
_version_ 1784670170609876992
author Al Haboob, Ali A.
author_facet Al Haboob, Ali A.
author_sort Al Haboob, Ali A.
collection PubMed
description COVID-19 infection displays heterogeneity of clinical manifestations in symptomatic and asymptomatic patients. We report on a child with Miller Fischer syndrome (MFS) and posterior reversible encephalopathy syndrome (PRES) post-COVID-19 infection. An 11-year-old boy presented with vomiting, headache, blurred vision, dysarthria, dysphagia, respiratory failure, muscle weakness, and unsteadiness. He had been exposed to COVID-19 through an asymptomatic elder brother two months prior to his illness. The MRI brain showed findings consistent with PRES and the diagnosis with Miller Fischer variant of the Guillain-Barré syndrome was made. A cerebrospinal fluid analysis revealed cytoalbuminous dissociation, and a nerve conduction velocity study conclusively showed polyneuropathy. A fluoroscopy of the diaphragms found that there was limited movement in both. Although children seem to be less affected by COVID-19 infection, this report highlights on an important neurological complications that can develop in children and its presence should be taken into consideration when diagnosing different forms of Guillain-Barré.
format Online
Article
Text
id pubmed-8926123
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Riyadh : Armed Forces Hospital
record_format MEDLINE/PubMed
spelling pubmed-89261232022-03-24 Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection Al Haboob, Ali A. Neurosciences (Riyadh) Case Reports COVID-19 infection displays heterogeneity of clinical manifestations in symptomatic and asymptomatic patients. We report on a child with Miller Fischer syndrome (MFS) and posterior reversible encephalopathy syndrome (PRES) post-COVID-19 infection. An 11-year-old boy presented with vomiting, headache, blurred vision, dysarthria, dysphagia, respiratory failure, muscle weakness, and unsteadiness. He had been exposed to COVID-19 through an asymptomatic elder brother two months prior to his illness. The MRI brain showed findings consistent with PRES and the diagnosis with Miller Fischer variant of the Guillain-Barré syndrome was made. A cerebrospinal fluid analysis revealed cytoalbuminous dissociation, and a nerve conduction velocity study conclusively showed polyneuropathy. A fluoroscopy of the diaphragms found that there was limited movement in both. Although children seem to be less affected by COVID-19 infection, this report highlights on an important neurological complications that can develop in children and its presence should be taken into consideration when diagnosing different forms of Guillain-Barré. Riyadh : Armed Forces Hospital 2021-07 /pmc/articles/PMC8926123/ /pubmed/34230086 http://dx.doi.org/10.17712/nsj.2021.3.20210002 Text en Copyright: © Neurosciences https://creativecommons.org/licenses/by-nc/3.0/Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.
spellingShingle Case Reports
Al Haboob, Ali A.
Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection
title Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection
title_full Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection
title_fullStr Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection
title_full_unstemmed Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection
title_short Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection
title_sort miller fischer and posterior reversible encephalopathy syndromes post covid-19 infection
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926123/
https://www.ncbi.nlm.nih.gov/pubmed/34230086
http://dx.doi.org/10.17712/nsj.2021.3.20210002
work_keys_str_mv AT alhaboobalia millerfischerandposteriorreversibleencephalopathysyndromespostcovid19infection